InvestorsHub Logo
Followers 61
Posts 3376
Boards Moderated 1
Alias Born 12/26/2012

Re: Solantey post# 53770

Sunday, 02/03/2013 12:55:24 PM

Sunday, February 03, 2013 12:55:24 PM

Post# of 130503
Fast Track, Accelerated Approval and Priority Review
Accelerating Availability of New Drugs for Patients with Serious Diseases


You time frame is way off especially with the Orphan Drug Status they AMBS are also pursuing read this....

http://www.fda.gov/forconsumers/byaudience/forpatientadvocates/speedingaccesstoimportantnewtherapies/ucm128291.htm#fast